Achieving hemostasis with the JADA system after induced abortion at 12 weeks: A case report
Contraception · 2025
DOI: 10.1016/j.contraception.2025.110855 ↗Kurz gefasst
Fallbericht in der Zeitschrift Contraception, 2025. Verfasst von Serena Ly und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Davis School of Medicine, Sacramento, CA, USA. Electronic address: sehly@ucdavis.edu. Hauptthemen laut MEDLINE: Abortion, Induced, Postpartum Hemorrhage, Uterine Inertia. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
The JADA system is safe and effective for control of abnormal postpartum bleeding and hemorrhage at gestational ages (GA) greater than 34 weeks. This report describes successful use of the JADA to control significant uterine atony and hemorrhage in a patient undergoing procedural abortion at 12 weeks 3 days gestation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of California, Davis School of Medicine, Sacramento, CA, USA. Electronic address: sehly@ucdavis.edu.
- Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA.
Zitieren
APA
Ly, S., Yazdani, S., & Economou, N. (2025). Achieving hemostasis with the JADA system after induced abortion at 12 weeks: A case report. Contraception. https://doi.org/10.1016/j.contraception.2025.110855
Vancouver
Ly S, Yazdani S, Economou N. Achieving hemostasis with the JADA system after induced abortion at 12 weeks: A case report. Contraception. 2025. doi:10.1016/j.contraception.2025.110855
BibTeX
@article{Ly2025,
author = {Ly, Serena and Yazdani, Sheeva and Economou, Nicole},
title = {Achieving hemostasis with the JADA system after induced abortion at 12 weeks: A case report},
journal = {Contraception},
year = {2025},
doi = {10.1016/j.contraception.2025.110855}
}
EUVIMED